首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

2038947

尼帕感染疾病市場：依產品類型、檢測類型、技術平台、檢體類型、最終用戶和地區分類

Nipah Virus Infection Market, By Product Type, By Test Type, By Technology Platform, By Sample Type, By End User, By Geography

出版日期: 2026年04月06日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，尼帕感染疾病市場規模將達到 5,480 萬美元，到 2033 年將達到 1.236 億美元。預計從 2026 年到 2033 年，該市場將以 12.32% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	5480萬美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	12.32%	2033年市場規模預測：	1.236億美元

全球尼帕病毒感染疾病市場是感染疾病管理領域的關鍵細分市場，涵蓋了近年來發現的最嚴重的感染疾病之一。

尼帕感染疾病最早於1998年在馬來西亞的疫情中被發現，它是一種副黏病毒，可導致感染者出現嚴重的腦炎和呼吸道疾病，死亡率在40%至75%之間。此疾病透過豬等中間宿主從受感染的果蝠傳播給人類，或透過直接接觸受感染果蝠的分泌物傳播，是孟加拉、印度和東南亞等流行國家的主要公共衛生問題。

這種病毒具有引發全球大流行的巨大潛力，已被世界衛生組織列為優先病原體，這引起了市場的廣泛關注，並凸顯了研發的必要性。通用感染疾病率的上升，加上人們對生物安全威脅的認知不斷提高以及監測系統的加強，正推動製藥公司、生物技術公司和公共衛生機構持續投資，從而在尼帕感染疾病領域創造了一個充滿創新活力的市場環境。

市場動態

全球尼帕感染疾病市場成長的促進因素包括通用感染疾病發病率上升、全球對疫情應對的重視以及各國政府和國際組織對新興感染疾病投入的增加。世界衛生組織將尼帕病毒列為優先病原體，以及感染疾病防範創新聯盟（CEPI）等組織加大對尼帕病毒疫苗研發的投入，都推動了市場成長。

此外，受影響地區加速的都市化和森林砍伐也在推動市場發展。這是因為動物與人類接觸的增加提高了感染傳播的風險。分子診斷市場技術的快速進步，特別是即時PCR和次世代定序技術的進步，也正在推動市場發展。

然而，市場也存在著許多限制因素。特別是，疫情的零星性和局部導致醫藥市場投資機會的商業性興趣不高。疫苗和藥物研發成本高昂，以及臨床試驗進行困難，也是限制市場發展的重大因素。此外，醫療基礎設施的匱乏，尤其是在疫情嚴重的地區，也是限制市場發展的一大障礙。

儘管市場仍存在諸多阻礙因素，但夥伴關係與協同研究的機會也顯著增加。此外，生物安全領域的趨勢至關重要，預計將對未來的市場潛力產生積極影響，尤其是在「同一健康」理念和快速疫苗研發技術的應用方面。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球尼帕病毒感染疾病市場的主要參與者進行了分析：公司亮點、產品系列、關鍵亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球尼帕感染疾病市場報告旨在為行業內的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過對全球尼帕感染疾病市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

BioPerfectus
Molbio Diagnostics
Huwel Lifesciences
BGI Genomics
ELK Biotechnology
Creative Diagnostics
RayBiotech
Abbexa
AntibodySystem
Alpha Diagnostic Intl

第11章分析師建議

機會
分析師意見
連貫的機會地圖

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9422

Nipah Virus Infection Market is estimated to be valued at USD 54.8 Mn in 2026 and is expected to reach USD 123.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.32% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 54.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.32%	2033 Value Projection:	USD 123.6 Mn

The global Nipah virus infection market is an important segment in the infectious disease management domain, which targets one of the most critical infectious diseases identified in recent times.

Nipah virus infection, first identified during an epidemic in Malaysia in 1998, is a paramyxovirus that results in severe encephalitis and respiratory disease in infected human beings, with a case fatality rate ranging between 40% and 75%. The disease spreads from infected fruit bats to human beings, either through an intermediate host, such as pigs, or through direct contact with infected bat secretions, thereby becoming a major cause of public health concern in endemic countries such as Bangladesh, India, and Southeast Asia.

The market has attracted significant attention owing to the high potential of the virus to cause a pandemic and its inclusion as a priority pathogen by the WHO, thereby emphasizing the need for R&D. The rising incidence rate of zoonotic disease outbreaks, combined with the increased recognition of biosecurity threats and the improvement in surveillance, is contributing to the continued investment by pharmaceutical companies, biotechnology companies, and public health organizations, thereby creating an innovative market scenario in the case of Nipah virus infection.

Market Dynamics

The global market for Nipah virus infection is influenced by the rising incidence rate of zoonotic infections, the global focus on pandemic preparedness, and the increased government and international funding levels for emerging infectious diseases. The WHO's categorization of the Nipah virus as a priority pathogen is driving the growth of the market, as is the increased funding support from organizations such as the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of vaccines against the Nipah virus.

Moreover, the increased rate of urbanization and deforestation in endemic regions is driving the market, as the increased rate of interaction between animals and humans is elevating the risk of the spread of the infection. The increased rate of technological advancements in the molecular diagnostics market, especially in the case of real-time PCR and next-generation sequencing, is driving the market.

However, the market is also affected by significant restraints, especially because of the sporadic and localized nature of the infection, causing less commercial interest in investment opportunities in the pharmaceutical market. The high cost of development of vaccines and medicines, along with the difficulties encountered while conducting clinical trials, are significant restraints to the market. The lack of healthcare infrastructure is also a significant restraint to the market, especially in endemic areas.

Even though the market is affected by significant restraints, the market is also affected by significant opportunities for partnerships and collaborations, and the trend of biosecurity is significant and is expected to have positive implications for the potential of the market in the future, especially through the use of One Health and rapid vaccine development technologies.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Nipah virus infection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include BioPerfectus, Molbio Diagnostics, Huwel Lifesciences, BGI Genomics, ELK Biotechnology, Creative Diagnostics, RayBiotech, Abbexa, AntibodySystem, and Alpha Diagnostic Intl
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Nipah virus infection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Nipah virus infection market

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Assay kits
- Instruments/Analyzers
- Reagents and Consumables
Test Type Insights (Revenue, USD Mn, 2021 - 2033)
- Molecular Tests
- Serology Tests
- Antigen-Detection Tests
- Confirmatory/Specialized Tests
Technology Platform Insights (Revenue, USD Mn, 2021 - 2033)
- PCR-Based Testing
- ELISA
- Lateral Flow
- Next-Generation Sequencing
- Others
Sample Type Insights (Revenue, USD Mn, 2021 - 2033)
- Blood/ Serum
- Urine
- Cerebrospinal Fluid (CSF)
- Throat Swab
- Nasal Swab
End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals and Infectious Disease Centers
- Public Health Agencies
- Reference Laboratories
- Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- BioPerfectus
- Molbio Diagnostics
- Huwel Lifesciences
- BGI Genomics
- ELK Biotechnology
- Creative Diagnostics
- RayBiotech
- Abbexa
- AntibodySystem
- Alpha Diagnostic Intl

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Nipah Virus Infection Market, By Product Type
- Global Nipah Virus Infection Market, By Test Type
- Global Nipah Virus Infection Market, By Technology Platform
- Global Nipah Virus Infection Market, By Sample Type
- Global Nipah Virus Infection Market, By End User
- Global Nipah Virus Infection Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trends

4. Global Nipah Virus Infection Market, By Product Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Assay kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Instruments/Analyzers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Reagents and Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Nipah Virus Infection Market, By Test Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Molecular Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Serology Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Antigen-Detection Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Confirmatory/Specialized Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Nipah Virus Infection Market, By Technology Platform, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
PCR-Based Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
ELISA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Lateral Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Next-Generation Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Nipah Virus Infection Market, By Sample Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Blood/ Serum
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Cerebrospinal Fluid (CSF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Throat Swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Nasal Swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Nipah Virus Infection Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals and Infectious Disease Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Public Health Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Reference Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global Nipah Virus Infection Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

BioPerfectus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Molbio Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Huwel Lifesciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BGI Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ELK Biotechnology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Creative Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
RayBiotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbexa
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AntibodySystem
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alpha Diagnostic Intl
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies